Suppr超能文献

IKKepsilon 对雌激素受体 α Ser-167 的磷酸化作用及其在乳腺癌中对他莫昔芬耐药性的贡献。

IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.

机构信息

From the Departments of Molecular Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida 33612.

Departments of Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida 33612.

出版信息

J Biol Chem. 2010 Feb 5;285(6):3676-3684. doi: 10.1074/jbc.M109.078212. Epub 2009 Nov 23.

Abstract

IKKepsilon has recently been identified as a breast cancer oncogene. Elevated levels of IKKepsilon are associated with cell survival and growth. Here, we show that IKKepsilon interacts with and phosphorylates estrogen receptor alpha (ERalpha) on serine 167 in vitro and in vivo. As a result, IKKepsilon induces ERalpha transactivation activity and enhances ERalpha binding to DNA. Cyclin D1, a major target of ERalpha, is transcriptionally up-regulated by IKKepsilon in a phospho-ERalpha-Ser-167-dependent manner. Further, overexpression of IKKepsilon induces tamoxifen resistance, whereas knockdown of IKKepsilon sensitizes cells to tamoxifen-induced cell death. These data suggest that ERalpha is a bona fide substrate of IKKepsilon and IKKepsilon plays an important role in tamoxifen resistance. Thus, IKKepsilon represents a critical therapeutic target in breast cancer.

摘要

IKKepsilon 最近被确定为乳腺癌致癌基因。IKKepsilon 的高水平与细胞存活和生长有关。在这里,我们表明 IKKepsilon 在体外和体内与雌激素受体 alpha (ERalpha)相互作用并使其丝氨酸 167 磷酸化。结果,IKKepsilon 诱导 ERalpha 转录激活活性并增强 ERalpha 与 DNA 的结合。细胞周期蛋白 D1 是 ERalpha 的主要靶标,IKKepsilon 通过依赖于磷酸化 ERalpha-Ser-167 的方式转录上调。此外,过表达 IKKepsilon 诱导他莫昔芬耐药,而敲低 IKKepsilon 则使细胞对他莫昔芬诱导的细胞死亡敏感。这些数据表明 ERalpha 是 IKKepsilon 的真正底物,IKKepsilon 在他莫昔芬耐药中发挥重要作用。因此,IKKepsilon 是乳腺癌的一个关键治疗靶点。

相似文献

1
IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.
J Biol Chem. 2010 Feb 5;285(6):3676-3684. doi: 10.1074/jbc.M109.078212. Epub 2009 Nov 23.
3
Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer.
Oncogene. 2014 Oct 16;33(42):4985-96. doi: 10.1038/onc.2013.444. Epub 2013 Oct 28.
5
Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells.
Mol Cell. 2017 Mar 16;65(6):1122-1135.e5. doi: 10.1016/j.molcel.2017.02.008.
6
Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.
J Natl Cancer Inst. 2011 Apr 6;103(7):538-52. doi: 10.1093/jnci/djr058. Epub 2011 Mar 29.
8
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
J Biol Chem. 2001 Mar 30;276(13):9817-24. doi: 10.1074/jbc.M010840200. Epub 2001 Jan 3.
9
Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer.
Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):E601-10. doi: 10.1073/pnas.1316255111. Epub 2014 Jan 21.
10
Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.
Breast Cancer Res Treat. 2015 Nov;154(2):225-37. doi: 10.1007/s10549-015-3609-7. Epub 2015 Oct 20.

引用本文的文献

2
IκB kinase-ε-mediated phosphorylation triggers IRF-1 degradation in breast cancer cells.
Neoplasia. 2020 Oct;22(10):459-469. doi: 10.1016/j.neo.2020.07.004. Epub 2020 Aug 9.
3
Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer.
Int J Mol Sci. 2020 Feb 11;21(4):1199. doi: 10.3390/ijms21041199.
4
Prognostic significance of preoperative IKBKE expression in esophageal squamous cell carcinoma.
Onco Targets Ther. 2018 Mar 7;11:1305-1314. doi: 10.2147/OTT.S156818. eCollection 2018.
5
mTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression.
Cell Death Differ. 2017 Nov;24(11):1886-1899. doi: 10.1038/cdd.2017.110. Epub 2017 Jul 7.
9
Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling.
Cytokine. 2015 Sep;75(1):117-26. doi: 10.1016/j.cyto.2014.12.007. Epub 2015 Jun 20.
10
Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer.
J Steroid Biochem Mol Biol. 2015 Jun;150:17-23. doi: 10.1016/j.jsbmb.2014.12.014. Epub 2015 Mar 12.

本文引用的文献

1
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.
Nature. 2009 Nov 5;462(7269):108-12. doi: 10.1038/nature08460. Epub 2009 Oct 21.
2
Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer.
Am J Pathol. 2009 Jul;175(1):324-33. doi: 10.2353/ajpath.2009.080767. Epub 2009 Jun 4.
4
S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation.
J Biol Chem. 2009 Mar 6;284(10):6361-9. doi: 10.1074/jbc.M807532200. Epub 2008 Dec 27.
5
MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer.
J Biol Chem. 2008 Nov 7;283(45):31079-86. doi: 10.1074/jbc.M806041200. Epub 2008 Sep 12.
6
Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
J Clin Oncol. 2007 Dec 20;25(36):5815-24. doi: 10.1200/JCO.2007.11.3886. Epub 2007 Sep 24.
7
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
Cell. 2007 Jun 15;129(6):1065-79. doi: 10.1016/j.cell.2007.03.052.
8
Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity.
Science. 2007 Mar 2;315(5816):1274-8. doi: 10.1126/science.1136567.
10
Characterization of a novel PMA-inducible pathway of interleukin-13 gene expression in T cells.
Immunology. 2006 Jan;117(1):29-37. doi: 10.1111/j.1365-2567.2005.02260.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验